<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04326699</url>
  </required_header>
  <id_info>
    <org_study_id>15/3/2020</org_study_id>
    <nct_id>NCT04326699</nct_id>
  </id_info>
  <brief_title>Bilateral Sacroiliac Joint (SIJ) Injection in Lumbar Disc Prolapse</brief_title>
  <official_title>Therapeutic Potentials of Bilateral Sacroiliac Joint Injection in Lumbar Disc Prolapse: a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bilateral sacroiliac joint injection in symptomatic lumbar disc prolapse under ultrasound
      guidance and studying the effect of this technique on pain, spine mobility and activity of
      daily living.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      86 Patients with lumbar disc prolapse diagnosed by either MRI or CT will be included. All of
      them aged &gt; 18 years with no special condition for the duration of disc prolapse. All of them
      had clinical manifestations in the form of mechanical low back pain or sciatica or limited
      spine mobility. All participants had no or poor response to conservative treatment. Previous
      surgery, severe facet arthropathy, ankylosing spondylitis, sensory or motor deficit and wedge
      fracture were considered as exclusion criteria. Distraction, compression, thigh thrust, and
      sacral thrust were used to assess SIJ dysfunction only at baseline before injection.
      Fingertip to floor and Oswestry disability index (ODI) were used to assess mobility and
      function of the spine at baseline (before and after injection) and after 2 and 16 weeks.
      Visual Analogue Scale (VAS) was used for pain appraisal at the same intervals. Participants
      will be randomly assigned into active and control group using 1:1 allocation. In the active
      group bilateral SIJ injection will be performed under ultrasound US guidance. Under US
      guidance a 22G spinal needle, where 1 mL 2 % lidocaine hydrochloride (xylocaine, AstraZeneca)
      mixed with triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip) will be injected in
      each SIJ.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2020</start_date>
  <completion_date type="Anticipated">October 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain assessment by visual analogue scale.</measure>
    <time_frame>at baseline 0 time, after 2 weeks and after 16 weeks</time_frame>
    <description>Visual analogue scale, 0 means no pain and 10 means the maximum possible pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spine mobility, finger tip to floor test</measure>
    <time_frame>Baseline 0 time, after 2 weeks and after 16 weeks</time_frame>
    <description>comparison to the intial values with each visit to detect changes with no definite references.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry disability index</measure>
    <time_frame>Baseline 0 time, after 2 weeks and after 16 weeks</time_frame>
    <description>0 value means no disability and 100 means complete disability</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">86</enrollment>
  <condition>Lumbar Disc Herniation</condition>
  <condition>Sciatica</condition>
  <condition>Low Back Pain, Mechanical</condition>
  <condition>Spine Stiffness</condition>
  <arm_group>
    <arm_group_label>Sacroiliac joint injection group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The active group will receive bilateral sacroiliac joint injection of 1 mL 2 % lidocaine hydrochloride (xylocaine, AstraZeneca) mixed with triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip) under ultrasound guidance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The other group will not receive the sacroiliac joint injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bilateral SIJ injection</intervention_name>
    <description>under US guidance a 22G spinal needle, where 1 mL 2 % lidocaine hydrochloride (xylocaine, AstraZeneca) mixed with triamcinolone 40 milligrams (Kenacort, Bristol Myers Squip) will be injected in each SIJ</description>
    <arm_group_label>Sacroiliac joint injection group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Lumbar disc prolapse diagnosed by either MRI or CT were included.

          -  All of them aged &gt; 18 years

          -  No special condition for the duration of disc prolapse.

          -  All of them had clinical manifestations in the form of mechanical low back pain or
             sciatica or limited spine mobility.

          -  All participants had no or poor response to conservative treatment

        Exclusion Criteria:

          -  Previous surgery

          -  Severe facet arthropathy

          -  Ankylosing spondylitis

          -  Sensory or motor deficit

          -  Wedge fracture
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sohag university</name>
      <address>
        <city>Sohag</city>
        <zip>82749</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed M Elsaman</last_name>
      <phone>01147158755</phone>
      <email>m2319434@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ahmed M Elsaman, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 25, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2020</study_first_posted>
  <last_update_submitted>April 23, 2020</last_update_submitted>
  <last_update_submitted_qc>April 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Ahmed Mahrous</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Disc Prolapse</keyword>
  <keyword>sacroiliac joint</keyword>
  <keyword>Injection</keyword>
  <keyword>Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Displacement</mesh_term>
    <mesh_term>Sciatica</mesh_term>
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

